News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current RGC market cap is 44.5M. The company's latest EPS is USD -0.4512 and P/E is -7.58.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -391k | -812k | -1.38M | -7.62M | -6.27M |
| Net Income | -391k | -812k | -1.35M | -7.6M | -5.87M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 243k | 514k | 340k | 18.02M | 12.62M |
| Total Liabilities | 2.08M | 3.17M | 4.34M | 938k | 633k |
| Total Equity | -1.84M | -2.65M | -4M | 17.08M | 11.99M |
| Market Cap | 44.5M |
| Price to Earnings Ratio | -7.58 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.43 |
| Price to Book Ratio | 3.71 |
| Dividend Yield | - |
| Shares Outstanding | 13.01M |
| Average Volume (1 week) | 474 |
| Average Volume (1 Month) | 1.18k |
| 52 Week Change | -81.99% |
| 52 Week High | 19.53 |
| 52 Week Low | 3.11 |
| Spread (Intraday) | 0.47 (12.74%) |
| Company Name | Regencell Bioscience Holdings Ltd |
| Address |
11/f first commercial building hong kong 999077 |
| Website | https://www.regencellbioscience.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
